Ting Zhong

Jiangxi Province Key Laboratory Of Functional Organic Polymers
Nanchang, 330013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Development of novel nanoliposomes co-loaded with ROR1 inhibitor and Ce6 for the treatment of EGFR-TKIs resistant NSCLC by synergistic targeted inhibitor therapy and photodynamic therapy.

Development of novel nanoliposomes co-loaded with ROR1 inhibitor and Ce6 for the treatment of EGFR-TKIs resistant NSCLC by synergistic targeted inhibitor therapy and photodynamic therapy.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: March 31, 2026

Au-Mediated Enhanced Charge Separation in Cs2AgBiBr6/Au/UiO-66 for Photocatalytic Synthesis of Thiosulfonates.

Au-Mediated Enhanced Charge Separation in Cs2AgBiBr6/Au/UiO-66 for Photocatalytic Synthesis of Thiosulfonates.

Journal: Inorganic chemistry

Published: February 11, 2026

Comparative mechanistic insights into ACE inhibition by matrine and oxymatrine: The role of N-oxidation in interfacial complementarity.

Comparative mechanistic insights into ACE inhibition by matrine and oxymatrine: The role of N-oxidation in interfacial complementarity.

Journal: International journal of biological macromolecules

Published: October 28, 2025

Anti-NSCLC efficacy of a novel ROR1/PI3Kα/BRD4 multi-target inhibitor.

Anti-NSCLC efficacy of a novel ROR1/PI3Kα/BRD4 multi-target inhibitor.

Journal: Bioorganic & medicinal chemistry

Published: September 05, 2025

A new specific GluN2B partial antagonist ameliorates brain injury caused by ischemic stroke in rats.

A new specific GluN2B partial antagonist ameliorates brain injury caused by ischemic stroke in rats.

Journal: Bioorganic chemistry

Published: February 07, 2025

Discovery of 3-(2-aminobenzo[d]thiazol-5-yl) benzamide derivatives as potent anticancer agents via ROR1 inhibition.

Discovery of 3-(2-aminobenzo[d]thiazol-5-yl) benzamide derivatives as potent anticancer agents via ROR1 inhibition.

Journal: Bioorganic & medicinal chemistry

Published: August 12, 2024

Design and synthesis of novel derivatives of bisepoxylignans as potent anti-inflammatory agents involves the modulation of the M1/M2 microglia phenotype via TLR4/NF-κB signaling pathway.

Design and synthesis of novel derivatives of bisepoxylignans as potent anti-inflammatory agents involves the modulation of the M1/M2 microglia phenotype via TLR4/NF-κB signaling pathway.

Journal: European journal of medicinal chemistry

Published: May 25, 2024

Synthesis and antitumor activities of novel 3-(6-aminopyridin-3-yl)benzamide derivatives: Inducing cell cycle arrest and apoptosis via AURKB transcription inhibition.

Synthesis and antitumor activities of novel 3-(6-aminopyridin-3-yl)benzamide derivatives: Inducing cell cycle arrest and apoptosis via AURKB transcription inhibition.

Journal: Bioorganic chemistry

Published: April 07, 2024

Lead-free Cs2AgBiBr6 double perovskite microcrystals for effective visible-light photocatalytic thio/selenocyanation.

Lead-free Cs2AgBiBr6 double perovskite microcrystals for effective visible-light photocatalytic thio/selenocyanation.

Journal: Chemical communications (Cambridge, England)

Published: March 25, 2024

Dual-Ligand Synergistic Targeting Anti-Tumor Nanoplatforms with Cascade-Responsive Drug Release.

Dual-Ligand Synergistic Targeting Anti-Tumor Nanoplatforms with Cascade-Responsive Drug Release.

Journal: Pharmaceutics

Published: June 08, 2023

Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling.

Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling.

Journal: International journal of molecular sciences

Published: March 29, 2023

Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition.

Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition.

Journal: International journal of molecular sciences

Published: February 15, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026